U.S. market Closed. Opens in 11 hours 38 minutes

LBPH | Longboard Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/AN/AN/AN/A
Cost of Revenue5.00K5.00K1.00KN/A
Gross Profit-5.00K-5.00K-1.00KN/A
Operating Expenses56.75M44.80M27.84M14.40M
Selling, General & Admin13.00M10.16M8.06M9.77M
Research & Development43.75M34.64M19.77M4.63M
Other Operating ExpensesN/A16.00K-22.00KN/A
Operating Income-56.76M-44.80M-27.84M-14.40M
Other Expenses / Income2.34M853.00K42.00K-7.40K
Before Tax Income-54.42M-43.95M-27.80M-14.40M
Income Tax ExpensesN/A-853.00K-64.00K-14.40K
Net Income-54.42M-43.09M-27.73M-14.40M
Interest ExpensesN/A837.00KN/AN/A
Basic Shares Outstanding22.73M17.15M17.07M17.67M
Diluted Shares Outstanding22.73M17.15M17.07M17.67M
EBITDA-56.75M-44.80M-27.84M-14.40M
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-54.42M-43.11M-27.80M-14.41M
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙